ConductScience.org, home

Paper36089112

Discovery and preclinical evaluations of GST-HG131, a novel HBV antigen inhibitor for the treatment of chronic hepatitis B infection.

Hu Y and 21 others. Bioorg Med Chem Lett, 2022. Cited by 9 papers, by iCite.

Cite this record

ConductScience Library. Discovery and preclinical evaluations of GST-HG131, a novel HBV antigen inhibitor for the treatment of chronic hepatitis B infection. Papers, record 36089112. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36089112

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Discovery and preclinical evaluations of GST-HG131, a novel HBV antigen inhibitor for the treatment of chronic hepatitis B infection.
PubMed
Journal
Bioorg Med Chem Lett
PubMed
Year
2022
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
9
iCite
Relative citation ratio, by iCite
0.71
iCite
Revised in PubMed
2026-01-27
PubMed

Authors22

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Hu YYanbin
2Sun FFei
3Yuan QQiang
4Du JJinhua
5Hu LLihong
6Gu ZZhengxian
7Zhou QQiong
8Du XXiaoting
9He SShibo
10Sun YYa
11Wang QQian
12Fan LLirong
13Wang LLina
14Qin SShaohua
15Chen SShuhui
16Li JJian
17Wu WWenqiang
18Mao JJohn
19Zhou YYixin
20Zhou QQiaoyun

Source PubMed

See all 22 authorsDownload CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Hepatitis BMajor topic
Hepatitis B, ChronicMajor topic
Animals
Rats
Antigens, Surface
Antiviral Agents
DNA, Viral
Hepatitis B e Antigens
Hepatitis B Surface Antigens
Hepatitis B virus
Benzoxepins
Pyridines

Source PubMed

Download CSV of topics

Trials1

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's record
NCT04499443Safety, Tolerability and Pharmacokinetic Characteristics Evaluation of GST-HG131 TabletsDerived from the trialYes

Source ClinicalTrials.gov

Download CSV of trials

Cited by7

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 9 citations.

PMIDTitleJournalYearIn PapersSource
42865026Safety, Tolerability and Antiviral Activity of GST-HG131 in Chronic Hepatitis B: A Randomized, Double-Blind Phase IIa Study.Liver Int2026https://conductscience.org/library/papers/42865026PubMed
42281419KASL clinical practice guidelines for management of chronic hepatitis B Endorsed by the East Asia Liver Alliance (EALA).Clin Mol Hepatol2026https://conductscience.org/library/papers/42281419PubMed
41754527Direct Viral Mechanisms Underlying the Onset of HBV-Related Hepatocellular Carcinoma and Implications for Therapeutic Strategies.Viruses2026https://conductscience.org/library/papers/41754527PubMed
38543689Preclinical Antiviral and Safety Profiling of the HBV RNA Destabilizer AB-161.Viruses2024https://conductscience.org/library/papers/38543689PubMed
38428537"PROTAC" modified dihydroquinolizinones (DHQs) that cause degradation of PAPD-5 and inhibition of hepatitis A virus and hepatitis B virus, in vitro.Bioorg Med Chem Lett2024https://conductscience.org/library/papers/38428537PubMed
37755289The Battle for Survival: The Role of RNA Non-Canonical Tails in the Virus-Host Interaction.Metabolites2023https://conductscience.org/library/papers/37755289PubMed
37009498The progress of molecules and strategies for the treatment of HBV infection.Front Cell Infect Microbiol2023https://conductscience.org/library/papers/37009498PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36089112

GET https://conductscience.org/api/papers/v1/36089112/authors?page=2